Neratinib Completed Phase 1 Trials for Neoplasms / Malignant Carcinoma Treatment

IndicationsStatusPurposePhase
CompletedTreatment1
clinicaltrials.gov IdentifierTitleDrugs
NCT00838539Study Evaluating Neratinib In Combination With Temsirolimus In Subjects With Solid Tumors